Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
Chavez, Julio C., MD, Piris-Villaespesa, Miguel, MD, Dalia, Samir, MD, Powers, John, PhD, Turba, Elyce, RN, Nodzon, Lisa, ARNP, Komrokji, Rami, MD, Sokol, Lubomir, PhD, Locke, Frederick L., MD, Lancet, Jeffrey, MD, Sotomayor, Eduardo M., MD, Kharfan-Dabaja, Mohamed A., MD, Pinilla-Ibarz, Javier, MD, PhD
Published in Leukemia research (01.08.2016)
Published in Leukemia research (01.08.2016)
Get full text
Journal Article
Therapeutic Updates for Richter Syndrome: Highlights From SOHO 2021
Nodzon, PhD, ARNP, AOCNP, Lisa
Published in Journal of the advanced practitioner in oncology (01.01.2022)
Published in Journal of the advanced practitioner in oncology (01.01.2022)
Get full text
Journal Article
Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021
Nodzon, PhD, ARNP, AOCNP, Lisa
Published in Journal of the advanced practitioner in oncology (01.01.2022)
Published in Journal of the advanced practitioner in oncology (01.01.2022)
Get full text
Journal Article
Minimal Residual Disease in Chronic Lymphocytic Leukemia: Highlights From SOHO 2020
Nodzon, PhD, ARNP, AOCNP, Lisa
Published in Journal of the advanced practitioner in oncology (01.01.2021)
Published in Journal of the advanced practitioner in oncology (01.01.2021)
Get full text
Journal Article
Emerging Therapies in Myelofibrosis: Highlights From SOHO 2020
Nodzon, PhD, ARNP, AOCNP, Lisa
Published in Journal of the advanced practitioner in oncology (01.01.2021)
Published in Journal of the advanced practitioner in oncology (01.01.2021)
Get full text
Journal Article